Ribupatide TFA is a dual agonist of the gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It finds application in diabetes research.
Target:
Glucagon Receptor|||IGF-1R
* VAT and and shipping costs not included. Errors and price changes excepted
